Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

NCT02802657 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
141
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xiaodong Sun

Collaborators